Clinical Trials Insight: 700023814

Trial Profile

Clinical Trials Insight: 700023814

Planning
Phase of Trial: Phase III

Latest Information Update: 17 Nov 2008

At a glance

  • Drugs Antineoplastics; Thymalfasin
  • Indications Malignant melanoma
  • Focus Registrational; Therapeutic Use
  • Sponsors SciClone Pharmaceuticals
  • Most Recent Events

    • 17 Nov 2008 Agreement reached with US FDA on Special Protocol Assessment.
    • 20 Nov 2007 Planned start date adjusted from Q4 2007 to Q1 2008.
    • 14 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top